Biology of Infection with Borrelia burgdorferi

Infectious Disease Clinics of North America

Volumn 22, Issue 2, 2008, Pages 217-234

  Tilly, Kit ^a   Rosa, Patricia A ^a   Stewart, Philip E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; OUTER SURFACE PROTEIN C;

BACTERIAL COLONIZATION; BIOLOGY; BORRELIA BURGDORFERI; BORRELIA INFECTION; EXPERIMENTAL ANIMAL; EXTRACELLULAR MATRIX; GENETIC PROCEDURES; GENOME; HISTORY; INFECTION; LIFE CYCLE; LYME DISEASE; MAMMAL; MOLECULAR GENETICS; NONHUMAN; PATHOGENESIS; PROTEIN BINDING; REVIEW; SPIROCHETE; TICK;

ANIMALS; ARACHNID VECTORS; BORRELIA BURGDORFERI; DISEASE MODELS, ANIMAL; GENOME, BACTERIAL; HUMANS; LIFE CYCLE STAGES; LYME DISEASE; TICKS;

EID: 42949172303     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2007.12.013     Document Type: Review

References (173)

1. Burgdorfer W., Barbour A.G., Hayes S.F., et al. Lyme disease-a tick-borne spirochetosis?. Science 216 (1982) 1317-1319
2. Steere A.C. Lyme disease. N Engl J Med 345 2 (2001) 115-125
3. Wooten R.M., and Weis J.J. Host-pathogen interactions promoting inflammatory Lyme arthritis: use of mouse models for dissection of disease processes. Curr Opin Microbiol 4 3 (2001) 274-279
4. Fraser C.M., Casjens S., Huang W.M., et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390 (1997) 580-586
5. Casjens S., Palmer N., van Vugt R., et al. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol 35 3 (2000) 490-516
6. Centers for Disease Control and Prevention. Lyme disease-United States, 2003-2005. MMWR Morb Mortal Wkly Rep 56 23 (2007) 573-576
7. Steere A.C., Malawista S.E., Snydman D.R., et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 20 (1977) 7-17
8. Johnson R.C., Schmid G.P., Hyde F.W., et al. Borrelia burgdorferi sp. nov.: etiologic agent of Lyme disease. Int J Syst Bacteriol 34 (1984) 496-497
9. Baranton G., Postic D., Saint Girons I., et al. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 42 (1992) 378-383
10. van Dam A.P., Kuiper H., Vos K., et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis 17 (1993) 708-717
11. Fraser C.M., Norris S.J., Weinstock G.M., et al. Complete genome sequence of Treponema pallidum, the syphilis spirochete. Science 281 5375 (1998) 375-388
12. Glöckner G., Lehmann R., Romualdi A., et al. Comparative analysis of the Borrelia garinii genome. Nucleic Acids Res 32 20 (2004) 6038-6046
13. Glöckner G., Schulte-Spechtel U., Schilhabel M., et al. Comparative genome analysis: selection pressure on the Borrelia vls cassettes is essential for infectivity. BMC Genomics 7 (2006) 211-220
14. Barbour A.G., and Garon C.F. Linear plasmids of the bacterium Borrelia burgdorferi have covalently closed ends. Science 237 (1987) 409-411
15. Baril C., Richaud C., Baranton G., et al. Linear chromosome of Borrelia burgdorferi. Res Microbiol 140 (1989) 507-516
16. Ferdows M.S., and Barbour A.G. Megabase-sized linear DNA in the bacterium Borrelia burgdorferi, the Lyme disease agent. Proc Natl Acad Sci U S A 86 (1989) 5969-5973
17. Hyde F.W., and Johnson R.C. Characterization of a circular plasmid from Borrelia burgdorferi, etiologic agent of Lyme disease. J Clin Microbiol 26 (1988) 2203-2205
18. Palmer N., Fraser C., and Casjens S. Distribution of twelve linear extrachromosomal DNAs in natural isolates of Lyme disease spirochetes. J Bacteriol 182 9 (2000) 2476-2480
19. Terekhova D., Iyer R., Wormser G.P., et al. Comparative genome hybridization reveals substantial variation among clinical isolates of Borrelia burgdorferi sensu stricto with different pathogenic properties. J Bacteriol 188 17 (2006) 6124-6134
20. Jauris-Heipke S., Fuchs R., Motz M., et al. Genetic heterogeneity of the genes coding for the outer surface protein C (OspC) and the flagellin of Borrelia burgdorferi. Med Microbiol Immunol 182 (1993) 37-50
21. Livey I., Gibbs C.P., Schuster R., et al. Evidence for lateral transfer and recombination in OspC variation in Lyme disease Borrelia. Mol Microbiol 18 (1995) 257-269
22. Zhang J.R., Hardham J.M., Barbour A.G., et al. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 89 (1997) 275-285
23. Wilske B., Preac-Mursic V., Jauris S., et al. Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi. Infect Immun 61 (1993) 2182-2191
24. Wilske B., Busch U., Fingerle V., et al. Immunological and molecular variability of OspA and OspC. Implications for Borrelia vaccine development. Infection 24 2 (1996) 208-212
25. Kaiser G.E., and Doetsch R.N. Enhanced translational motion of Leptospira in viscous environments. Nature 255 5510 (1975) 656-657
26. Greenberg E.P., and Canale-Parola E. Motility of flagellated bacteria in viscous environments. J Bacteriol 132 1 (1977) 356-358
27. Berg H.C., and Turner L. Movement of microorganisms in viscous environments. Nature 278 5702 (1979) 349-351
28. Kimsey R.B., and Spielman A. Motility of Lyme disease spirochetes in fluids as viscous as the extracellular matrix. J Infect Dis 162 (1990) 1205-1208
29. Rosa P.A., Tilly K., and Stewart P.E. The burgeoning molecular genetics of the Lyme disease spirochaete. Nat Rev Microbiol 3 (2005) 129-143
30. Morozova O.V., Dubytska L.P., Ivanova L.B., et al. Genetic and physiological characterization of 23S rRNA and ftsJ mutants of Borrelia burgdorferi isolated by mariner transposition. Gene 357 1 (2005) 63-72
31. Stewart P.E., Hoff J., Fischer E., et al. Genome-wide transposon mutagenesis of Borrelia burgdorferi for identification of phenotypic mutants. Appl Environ Microbiol 70 10 (2004) 5973-5979
32. Botkin D.J., Abbott A., Stewart P.E., et al. Identification of potential virulence determinants by HimarI transposition of infectious Borrelia burgdorferi B31. Infect Immun 74 12 (2006) 6690-6699
33. Anderson J.F., and Magnarelli L.A. Avian and mammalian hosts for spirochete-infected ticks and insects in a Lyme disease focus in Connecticut. Yale J Biol Med 57 4 (1984) 627-641
34. Levine J.F., Wilson M.L., and Spielman A. Mice as reservoirs of the Lyme disease spirochete. Am J Trop Med Hyg 34 (1985) 355-360
35. Anderson J.F., Johnson R.C., Magnarelli L.A., et al. Involvement of birds in the epidemiology of the Lyme disease agent Borrelia burgdorferi. Infect Immun 51 2 (1986) 394-396
36. Donahue J.G., Piesman J., and Spielman A. Reservoir competence of white-footed mice for Lyme disease spirochetes. Am J Trop Med Hyg 36 (1987) 92-96
37. Brown R.N., and Lane R.S. Lyme disease in California: a novel enzootic transmission cycle of Borrelia burgdorferi. Science 256 (1992) 1439-1442
38. Levin M., Levine J.F., Yang S., et al. Reservoir competence of the southeastern five-lined skink (Eumeces inexpectatus) and the green anole (Anolis carolinensis) for Borrelia burgdorferi. Am J Trop Med Hyg 54 1 (1996) 92-97
39. Clark K., Hendricks A., and Burge D. Molecular identification and analysis of Borrelia burgdorferi sensu lato in lizards in the southeastern United States. Appl Environ Microbiol 71 5 (2005) 2616-2625
40. Lane R.S., Piesman J., and Burgdorfer W. Lyme borreliosis: relation of its causative agent to its vectors and hosts in North America and Europe. Annu Rev Entomol 36 (1991) 587-609
41. Burgdorfer W., Lane R.S., Barbour A.G., et al. The western black-legged tick, Ixodes pacificus, a vector of Borrelia burgdorferi. Am J Trop Med Hyg 34 (1985) 925-930
42. Gern L., and Humair P.F. Ecology of Borrelia burgdorferi sensu lato in Europe. In: Gray J.S., Kahl O., Lane R.S., et al. (Eds). Lyme borreliosis: biology, epidemiology and control (2002), CABI Publishing, Wallingford (UK) 149-174
43. Korenberg E.I., Gorelova N.B., and Kovalevskii Y.V. Ecology of Borrelia burgdorferi sensu lato in Russia. In: Gray J.S., Kahl O., Lane R.S., et al. (Eds). Lyme borreliosis: biology, epidemiology and control (2002), CABI Publishing, Wallingford (UK) 175-200
44. Mather T.N., Wilson M.L., Moore S.I., et al. Comparing the relative potential of rodents as reservoirs of the Lyme disease spirochete (Borrelia burgdorferi). Am J Epidemiol 130 1 (1989) 143-150
45. Burgdorfer W., Hayes S.F., and Corwin D. Pathophysiology of the Lyme disease spirochete, Borrelia burgdorferi, in ixodid ticks. Rev Infect Dis 11 Suppl 6 (1989) S1442-S1450
46. Patrican L.A. Absence of Lyme disease spirochetes in larval progeny of naturally infected Ixodes scapularis (Acari: Ixodidae) fed on dogs. J Med Entomol 34 1 (1997) 52-55
47. Balashov Y.S. Bloodsucking ticks (Ixodoidea)-vectors of diseases of man and animals. Miscellaneous Publications of the Entomological Society of America 8 (1972) 161-376
48. Ribeiro J.M.C. The midgut hemolysin of Ixodes dammini (Acari: Ixodidae). J Parasitol 74 (1988) 532-537
49. Schwan T.G., Piesman J., Golde W.T., et al. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci U S A 92 (1995) 2909-2913
50. Carroll J.A., Garon C.F., and Schwan T.G. Effects of environmental pH on membrane proteins in Borrelia burgdorferi. Infect Immun 67 (1999) 3181-3187
51. Schwan T.G., and Piesman J. Temporal changes in outer surface proteins A and C of the Lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice. J Clin Microbiol 39 1 (2000) 382-388
52. Carroll J.A., Cordova R.M., and Garon C.F. Identification of 11 pH-regulated genes in Borrelia burgdorferi localizing to linear plasmids. Infect Immun 68 12 (2000) 6677-6684
53. Yang X., Goldberg M.S., Popova T.G., et al. Interdependence of environmental factors influencing reciprocal patterns of gene expression in virulent Borrelia burgdorferi. Mol Microbiol 37 6 (2000) 1470-1479
54. Philipp M.T., and Johnson B.J.B. Animal models of Lyme disease: pathogenesis and immunoprophylaxis. Trends Microbiol 2 (1994) 431-437
55. Johnson R.C., Marek N., and Kodner C. Infection of Syrian hamsters with Lyme disease spirochetes. J Clin Microbiol 20 (1984) 1099-1101
56. Schmitz J.L., Schell R.F., Hejka A., et al. Induction of Lyme arthritis in LSH hamsters. Infect Immun 56 (1988) 2336-2342
57. Lim L.C., England D.M., DuChateau B.K., et al. Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi. Infect Immun 62 7 (1994) 2825-2833
58. Burgdorfer W. The New Zealand white rabbit: an experimental host for infecting ticks with Lyme disease spirochetes. Yale J Biol Med 57 4 (1984) 609-612
59. Kornblatt A.N., Steere A.C., and Brownstein D.G. Infection in rabbits with the Lyme disease spirochete. Yale J Biol Med 57 4 (1984) 613-616
60. Appel M.J., Allan S., Jacobson R.H., et al. Experimental Lyme disease in dogs produces arthritis and persistent infection. J Infect Dis 167 (1993) 651-654
61. Philipp M.T., Aydintug M.K., Bohm Jr. R.P., et al. Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans. Infect Immun 61 7 (1993) 3047-3059
62. Pachner A.R., Delaney E., O'Neill T., et al. Inoculation of nonhuman primates with the N40 strain of Borrelia burgdorferi leads to a model of Lyme neuroborreliosis faithful to the human disease. Neurology 45 1 (1995) 165-172
63. Roberts E.D., Bohm Jr. R.P., Cogswell F.B., et al. Chronic Lyme disease in the rhesus monkey. Lab Invest 72 2 (1995) 146-160
64. Roberts E.D., Bohm Jr. R.P., Lowrie Jr. R.C., et al. Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system. J Infect Dis 178 3 (1998) 722-732
65. Schwan T.G., Burgdorfer W., Schrumpf M.E., et al. The urinary bladder, a consistent source of Borrelia burgdorferi in experimentally infected white-footed mice (Peromyscus leucopus). J Clin Microbiol 26 (1988) 893-895
66. Barthold S.W., Beck D.S., Hansen G.M., et al. Lyme borreliosis in selected strains and ages of laboratory mice. J Infect Dis 162 (1990) 133-138
67. Kang I., Barthold S.W., Persing D.H., et al. T-helper-cell cytokines in the early evolution of murine Lyme arthritis. Infect Immun 65 8 (1997) 3107-3111
68. Ma Y., Seiler K.P., Eichwald E.J., et al. Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect Immun 66 1 (1998) 161-168
69. Brown C.R., and Reiner S.L. Genetic control of experimental Lyme arthritis in the absence of specific immunity. Infect Immun 67 4 (1999) 1967-1973
70. Weis J.J., McCracken B.A., Ma Y., et al. Identification of quantitative trait loci governing arthritis severity and humoral responses in the murine model of Lyme disease. J Immunol 162 2 (1999) 948-956
71. Kumar H., Belperron A., Barthold S.W., et al. Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J Immunol 165 9 (2000) 4797-4801
72. Roper R.J., Weis J.J., McCracken B.A., et al. Genetic control of susceptibility to experimental Lyme arthritis is polygenic and exhibits consistent linkage to multiple loci on chromosome 5 in four independent mouse crosses. Genes Immun 2 7 (2001) 388-397
73. Crandall H., Ma Y., Dunn D.M., et al. Bb2Bb3 regulation of murine Lyme arthritis is distinct from Ncf1 and independent of the phagocyte nicotinamide adenine dinucleotide phosphate oxidase. Am J Pathol 167 3 (2005) 775-785
74. Guerau-de-Arellano M., Alroy J., Bullard D., et al. Aggravated Lyme carditis in CD11a-/- and CD11c-/- mice. Infect Immun 73 11 (2005) 7637-7643
75. Crandall H., Dunn D.M., Ma Y., et al. Gene expression profiling reveals unique pathways associated with differential severity of Lyme arthritis. J Immunol 177 11 (2006) 7930-7942
76. Hirschfeld M., Kirschning C.J., Schwandner R., et al. Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol 163 5 (1999) 2382-2386
77. Wooten R.M., Ma Y., Yoder R.A., et al. Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J Immunol 168 (2002) 348-355
78. Wang G., Ma Y., Buyuk A., et al. Impaired host defense to infection and toll-like receptor 2-independent killing of Borrelia burgdorferi clinical isolates in TLR2-deficient C3H/HeJ mice. FEMS Microbiol Lett 231 2 (2004) 219-225
79. Bolz D.D., Sundsbak R.S., Ma Y., et al. MyD88 plays a unique role in host defense but not arthritis development in Lyme disease. J Immunol 173 3 (2004) 2003-2010
80. Liu N., Montgomery R.R., Barthold S.W., et al. Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice. Infect Immun 72 6 (2004) 3195-3203
81. Behera A.K., Hildebrand E., Bronson R.T., et al. MyD88 deficiency results in tissue-specific changes in cytokine induction and inflammation in interleukin-18-independent mice infected with Borrelia burgdorferi. Infect Immun 74 3 (2006) 1462-1470
82. Bockenstedt L.K., Liu N., Schwartz I., et al. MyD88 deficiency enhances acquisition and transmission of Borrelia burgdorferi by Ixodes scapularis ticks. Infect Immun 74 4 (2006) 2154-2160
83. Kurtenbach K., Sewell H.S., Ogden N.H., et al. Serum complement sensitivity as a key factor in Lyme disease ecology. Infect Immun 66 3 (1998) 1248-1251
84. Lawrenz M.B., Wooten R.M., Zachary J.F., et al. Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice. Infect Immun 71 8 (2003) 4432-4440
85. Woodman M.E., Cooley A.E., Miller J.C., et al. Borrelia burgdorferi binding of host complement regulator factor H is not required for efficient mammalian infection. Infect Immun 75 6 (2007) 3131-3139
86. Magnarelli L.A., Anderson J.F., Hyland K.E., et al. Serologic analyses of Peromyscus leucopus, a rodent reservoir for Borrelia burgdorferi, in northeastern United States. J Clin Microbiol 26 6 (1988) 1138-1141
87. Schwan T.G., Kime K.K., Schrumpf M.E., et al. Antibody response in white-footed mice (Peromyscus leucopus) experimentally infected with the Lyme disease spirochete (Borrelia burgdorferi). Infect Immun 57 (1989) 3445-3451
88. Barthold S.W., and Bockenstedt L.K. Passive immunizing activity of sera from mice infected with Borrelia burgdorferi. Infect Immun 61 (1993) 4696-4702
89. Barthold S.W., deSouza M., and Feng S. Serum-mediated resolution of Lyme arthritis in mice. Lab Invest 74 1 (1996) 57-67
90. Schaible U.E., Wallich R., Kramer M.D., et al. Protection against Borrelia burgdorferi infection in SCID mice is conferred by presensitized spleen cells and partially by B but not T cells alone. Int Immunol 6 5 (1994) 671-681
91. Barthold S.W., Sidman C.L., and Smith A.L. Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am J Trop Med Hyg 47 (1992) 605-613
92. Schwan T.G., Karstens R.H., Schrumpf M.E., et al. Changes in antigenic reactivity of Borrelia burgdorferi, the Lyme disease spirochete, during persistent infection in mice. Can J Microbiol 37 (1991) 450-454
93. Revel A.T., Talaat A.M., and Norgard M.V. DNA microarray analysis of differential gene expression in Borrelia burgdorferi, the Lyme disease spirochete. Proc Natl Acad Sci U S A 99 3 (2002) 1562-1567
94. Ojaimi C., Brooks C., Casjens S., et al. Profiling temperature-induced changes in Borrelia burgdorferi gene expression using whole genome arrays. Infect Immun 71 4 (2003) 1689-1705
95. Tokarz R., Anderton J.M., Katona L.I., et al. Combined effects of blood and temperature shift on Borrelia burgdorferi gene expression as determined by whole genome DNA array. Infect Immun 72 9 (2004) 5419-5432
96. Brooks C.S., Hefty P.S., Jolliff S.E., et al. Global analysis of Borrelia burgdorferi genes regulated by mammalian host-specific signals. Infect Immun 71 6 (2003) 3371-3383
97. Narasimhan S., Santiago F., Koski R.A., et al. Examination of the Borrelia burgdorferi transcriptome in Ixodes scapularis during feeding. J Bacteriol 184 11 (2002) 3122-3125
98. Liang F.T., Nelson F.K., and Fikrig E. Molecular adaptation of Borrelia burgdorferi in the murine host. J Exp Med 196 2 (2002) 275-280
99. Hodzic E., Feng S., Freet K.J., et al. Borrelia burgdorferi population kinetics and selected gene expression at the host-vector interface. Infect Immun 70 7 (2002) 3382-3388
100. Hodzic E., Feng S., Freet K.J., et al. Borrelia burgdorferi population dynamics and prototype gene expression during infection of immunocompetent and immunodeficient mice. Infect Immun 71 9 (2003) 5042-5055
101. Narasimhan S., Caimano M.J., Liang F.T., et al. Borrelia burgdorferi transcriptome in the central nervous system of non-human primates. Proc Natl Acad Sci U S A 100 26 (2003) 15953-15958
102. Crother C.R., Champion C.I., Wu X.Y., et al. Antigenic composition of Borrelia burgdorferi during infection of SCID mice. Infect Immun 71 (2003) 3419-3428
103. Crother T.R., Champion C.I., Whitelegge J.P., et al. Temporal analysis of the antigenic composition of Borrelia burgdorferi during infection in rabbit skin. Infect Immun 72 9 (2004) 5063-5072
104. Schwan T.G., Burgdorfer W., and Garon C.F. Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation. Infect Immun 56 (1988) 1831-1836
105. Norris S.J., Howell J.K., Garza S.A., et al. High- and low-infectivity phenotypes of clonal populations of in vitro-cultured Borrelia burgdorferi. Infect Immun 63 6 (1995) 2206-2212
106. Xu Y., Kodner C., Coleman L., et al. Correlation of plasmids with infectivity of Borrelia burgdorferi sensu stricto type strain B31. Infect Immun 64 9 (1996) 3870-3876
107. Purser J.E., and Norris S.J. Correlation between plasmid content and infectivity in Borrelia burgdorferi. Proc Natl Acad Sci U S A 97 25 (2000) 13865-13870
108. Labandeira-Rey M., and Skare J.T. Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28-1. Infect Immun 69 1 (2001) 446-455
109. Purser J.E., Lawrenz M.B., Caimano M.J., et al. A plasmid-encoded nicotinamidase (PncA) is essential for infectivity of Borrelia burgdorferi in a mammalian host. Mol Microbiol 48 3 (2003) 753-764
110. Jewett M.W., Lawrence K., Bestor A.C., et al. The critical role of the linear plasmid lp36 in the infectious cycle of Borrelia burgdorferi. Mol Microbiol 64 5 (2007) 1358-1374
111. Posey J.E., and Gherardini F.C. Lack of a role for iron in the Lyme disease pathogen. Science 288 5471 (2000) 1651-1653
112. Liang F.T., Jacobs M.B., Bowers L.C., et al. An immune evasion mechanism for spirochetal persistence in Lyme borreliosis. J Exp Med 195 4 (2002) 415-422
113. Grimm D., Tilly K., Byram R., et al. Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. Proc Natl Acad Sci U S A 101 9 (2004) 3142-3147
114. Tilly K., Krum J.G., Bestor A., et al. Borrelia burgdorferi OspC protein required exclusively in a crucial early stage of mammalian infection. Infect Immun 74 6 (2006) 3554-3564
115. Stewart P.E., Wang X., Bueschel D.M., et al. Delineating the requirement for the Borrelia burgdorferi virulence factor OspC in the mammalian host. Infect Immun 74 6 (2006) 3547-3553
116. Tilly K., Bestor A., Jewett M.W., et al. Rapid clearance of Lyme disease spirochetes lacking OspC from skin. Infect Immun 75 3 (2007) 1517-1519
117. Labandeira-Rey M., Seshu J., and Skare J.T. The absence of linear plasmid 25 or 28-1 of Borrelia burgdorferi dramatically alters the kinetics of experimental infection via distinct mechanisms. Infect Immun 71 8 (2003) 4608-4613
118. Bankhead T., and Chaconas G. The role of VlsE antigenic variation in the Lyme disease spirochete: persistence through a mechanism that differs from other pathogens. Mol Microbiol 65 6 (2007) 1547-1558
119. Pal U., Yang X., Chen M., et al. OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J Clin Invest 113 2 (2004) 220-230
120. Fingerle V., Goettner G., Gern L., et al. Complementation of a Borrelia afzelii OspC mutant highlights the crucial role of OspC for dissemination of Borrelia afzelii in Ixodes ricinus. Int J Med Microbiol 297 2 (2007) 97-107
121. Montgomery R.R., Malawista S.E., Feen K.J.M., et al. Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease. J Exp Med 183 (1996) 261-269
122. Fingerle V., Liegl G., Munderloh U., et al. Expression of outer surface proteins A and C of Borrelia burgdorferi in Ixodes ricinus ticks removed from humans. Med Microbiol Immunol 187 2 (1998) 121-126
123. Liang F.T., Yan J., Mbow M.L., et al. Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Infect Immun 72 10 (2004) 5759-5767
124. Kumaran D., Eswaramoorthy S., Luft B.J., et al. Crystal structure of outer surface protein C (OspC) from the Lyme disease spirochete, Borrelia burgdorferi. EMBO J 20 5 (2001) 971-978
125. Eicken C., Sharma V., Klabunde T., et al. Crystal structure of Lyme disease antigen outer surface protein C from Borrelia burgdorferi. J Biol Chem 276 (2001) 10010-10015
126. Wilske B., Jauris-Heipke S., Labentanzer R., et al. Phenotypic analysis of outer surface protein C (OspC) of Borrelia burgdorferi sensu lato by monoclonal antibodies: relationship to genospecies and OspA serotype. J Clin Microbiol 33 (1995) 103-109
127. Wang I.N., Dykhuizen D.E., Qiu W., et al. Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto. Genetics 151 1 (1999) 15-30
128. Seinost G., Dykhuizen D.E., Dattwyler R.J., et al. Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immun 67 7 (1999) 3518-3524
129. Brisson D., and Dykhuizen D.E. ospC diversity in Borrelia burgdorferi: different hosts are different niches. Genetics 168 2 (2004) 713-722
130. Alghaferi M.Y., Anderson J.M., Park J., et al. Borrelia burgdorferi ospC heterogeneity among human and murine isolates from a defined region of northern Maryland and southern Pennsylvania: lack of correlation with invasive and noninvasive genotypes. J Clin Microbiol 43 4 (2005) 1879-1884
131. Lagal V., Portnoi D., Faure G., et al. Borrelia burgdorferi sensu stricto invasiveness is correlated with OspC-plasminogen affinity. Microbes Infect 8 3 (2006) 645-652
132. Earnhart C.G., Buckles E.L., Dumler J.S., et al. Demonstration of OspC type diversity in invasive human Lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response. Infect Immun 73 12 (2005) 7869-7877
133. Fuchs H., Wallich R., Simon M.M., et al. The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen) receptor. Proc Natl Acad Sci U S A 91 (1994) 12594-12598
134. Hu L.T., Perides G., Noring R., et al. Binding of human plasminogen to Borrelia burgdorferi. Infect Immun 63 9 (1995) 3491-3496
135. Coleman J.L., Gebbia J.A., Piesman J., et al. Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell 89 (1997) 1111-1119
136. Kraiczy P., Skerka C., Brade V., et al. Further characterization of complement regulator-acquiring surface proteins of Borrelia burgdorferi. Infect Immun 69 12 (2001) 7800-7809
137. Hellwage J., Meri T., Heikkilä T., et al. The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J Biol Chem 276 11 (2001) 8427-8435
138. Alitalo A., Meri T., Ramo L., et al. Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation. Infect Immun 69 6 (2001) 3685-3691
139. Stevenson B., El-hage N., Hines M.A., et al. Differential binding of host complement inhibitor factor H by Borrelia burgdorferi Erp surface proteins: a possible mechanism underlying the expansive host range of Lyme disease spirochetes. Infect Immun 70 2 (2002) 491-497
140. Kraiczy P., Hellwage J., Skerka C., et al. Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins. J Biol Chem 279 4 (2004) 2421-2429
141. Hartmann K., Corvey C., Skerka C., et al. Functional characterization of BbCRASP-2, a distinct outer membrane protein of Borrelia burgdorferi that binds host complement regulators factor H and FHL-1. Mol Microbiol 61 5 (2006) 1220-1236
142. Lawrenz M.B., Wooten R.M., and Norris S.J. Effects of vlsE complementation on the infectivity of Borrelia burgdorferi lacking the linear plasmid lp28-1. Infect Immun 72 11 (2004) 6577-6585
143. Cabello F.C., Godfrey H.P., and Newman S.A. Hidden in plain sight: Borrelia burgdorferi and the extracellular matrix. Trends Microbiol 15 8 (2007) 350-354
144. Coburn J., Fischer J.R., and Leong J.M. Solving a sticky problem: new genetic approaches to host cell adhesion by the Lyme disease spirochete. Mol Microbiol 57 5 (2005) 1182-1195
145. Guo B.P., Brown E.L., Dorward D.W., et al. Decorin-binding adhesins from Borrelia burgderferi. Mol Microbiol 30 4 (1998) 711-723
146. Probert W.S., and Johnson B.J. Identification of a 47 kDa fibronectin-binding protein expressed by Borrelia burgdorferi isolate B31. Mol Microbiol 30 5 (1998) 1003-1015
147. Parveen N., Cornell K., Bono J., et al. Bgp, a secreted GAG-binding protein of Borrelia burgdorferi strain N40, displays nucleosidase activity and is not essential for infection of immunodeficient mice. Infect Immun 74 5 (2006) 3016-3020
148. 3. Proc Natl Acad Sci U S A 100 12 (2003) 7301-7306
149. Shi Y., Xu Q., Seemanapalli S.V., et al. The dbpBA locus of Borrelia burgdorferi is not essential for infection of mice. Infect Immun 74 11 (2006) 6509-6512
150. Seshu J., Esteve-Gassent M.D., Labandeira-Rey M., et al. Inactivation of the fibronectin-binding adhesin gene bbk32 significantly attenuates the infectivity potential of Borrelia burgdorferi. Mol Microbiol 59 5 (2006) 1591-1601
151. Li X., Liu X., Beck D.S., et al. Borrelia burgdorferi lacking BBK32, a fibronectin-binding protein, retains full pathogenicity. Infect Immun 74 6 (2006) 3305-3313
152. Hübner A., Wang X., Nolen D.M., et al. Expression of Borrelia burgdorferi OspC and DbpA is controlled by a RpoN-RpoS regulatory pathway. Proc Natl Acad Sci U S A 98 22 (2001) 12724-12729
153. Fisher M.A., Grimm D., Henion A.K., et al. Borrelia burgdorferi sigma54 is required for mammalian infection and vector transmission but not for tick colonization. Proc Natl Acad Sci U S A 102 14 (2005) 5162-5167
154. Yang X.F., Alani S.M., and Norgard M.V. The response regulator Rrp2 is essential for the expression of major membrane lipoproteins in Borrelia burgdorferi. Proc Natl Acad Sci U S A 100 19 (2003) 11001-11006
155. Caimano M.J., Iyer R., Eggers C.H., et al. Analysis of the RpoS regulon in Borrelia burgdorferi in response to mammalian host signals provides insight into RpoS function during the enzootic cycle. Mol Microbiol 65 5 (2007) 1193-1217
156. Piesman J., Oliver J.R., and Sinsky R.J. Growth kinetics of the Lyme disease spirochete (Borrelia burgdorferi) in vector ticks (Ixodes dammini). Am J Trop Med Hyg 42 (1990) 352-357
157. de Silva A.M., and Fikrig E. Growth and migration of Borrelia burgdorferi in Ixodes ticks during blood feeding. Am J Trop Med Hyg 53 (1995) 397-404
158. Piesman J., Schneider B.J., and Zeidner N.S. Use of quantitative PCR to measure density of Borrelia burgdorferi in the midgut and salivary glands of feeding tick vectors. J Clin Microbiol 39 11 (2001) 4145-4148
159. de Silva A.M., Telford III S.R., Brunet L.R., et al. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med 183 (1996) 271-275
160. Ohnishi J., Piesman J., and de Silva A.M. Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. Proc Natl Acad Sci U S A 98 2 (2001) 670-675
161. de Silva A.M., Fish D., Burkot T.R., et al. OspA antibodies inhibit the acquisition of Borrelia burgdorferi by Ixodes ticks. Infect Immun 65 8 (1997) 3146-3150
162. Pal U., de Silva A.M., Montgomery R.R., et al. Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A. J Clin Invest 106 4 (2000) 561-569
163. Yang X.F., Pal U., Alani S.M., et al. Essential role for OspA/B in the life cycle of the Lyme disease spirochete. J Exp Med 199 5 (2004) 641-648
164. Fikrig E., Pal U., Chen M., et al. OspB antibody prevents Borrelia burgdorferi colonization of Ixodes scapularis. Infect Immun 72 3 (2004) 1755-1759
165. Boylan J.A., Posey J.E., and Gherardini F.C. Borrelia oxidative stress response regulator, BosR: a distinctive Zn-dependent transcriptional activator. Proc Natl Acad Sci U S A 100 20 (2003) 11684-11689
166. Neelakanta G., Li X., Pal U., et al. Outer surface protein B is critical for Borrelia burgdorferi adherence and survival within Ixodes ticks. PLoS Pathog 3 3 (2007) E33
167. Revel A.T., Blevins J.S., Almazan C., et al. bptA (bbe16) is essential for the persistence of the Lyme disease spirochete, Borrelia burgdorferi, in its natural tick vector. Proc Natl Acad Sci U S A 102 19 (2005) 6972-6977
168. Li X., Pal U., Ramamoorthi N., et al. The Lyme disease agent Borrelia burgdorferi requires BB0690, a Dps homologue, to persist within ticks. Mol Microbiol 63 3 (2007) 694-710
169. Ribeiro J.M., Alarcon-Chaidez F., Francischetti I.M., et al. An annotated catalog of salivary gland transcripts from Ixodes scapularis ticks. Insect Biochem Mol Biol 36 2 (2006) 111-129
170. Pal U., Li X., Wang T., et al. TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi. Cell 119 4 (2004) 457-468
171. Anguita J., Ramamoorthi N., Hovius J.W.R., et al. Salp15, an Ixodes scapularis salivary protein, inhibits CD4 + T cell activation. Immunity 16 (2002) 849-859
172. Ramamoorthi N., Narasimhan S., Pal U., et al. The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature 436 7050 (2005) 573-577
173. Narasimhan S., Sukumaran B., Bozdogan J., et al. A tick antioxidant facilitates the Lyme disease agent's successful migration from the mammalian host to the arthropod vector. Cell Host Microbe 2 (2007) 7-18